HyperClear:前立腺肥大症のレーザー治療
前立腺肥大症(BPH)を精密に治療するために設計された先進のレーザーシステムで、効果的な組織除去、尿流の改善、ダウンタイムの最小化を実現し、患者さんの治療成績を向上させます。
HyperClear represents an innovative laser therapy system designed to effectively remove surplus prostatic tissue in benign prostatic hyperplasia (BPH). Leveraging the LIFE (Laser-Induced Fiber Enucleation) method, HyperClear applies precise laser energy via a flexible fiber placed transurethrally to the obstructive zone, ablating the excess prostate tissue responsible for lower urinary tract symptoms (LUTS). This approach may be performed outpatient—often with local anesthesia—enhancing patient comfort while maintaining efficacy and safety.
High-Precision Laser Fiber
- Optimized Energy Delivery: The laser fiber is advanced through the urethra to the blocked area, targeting surplus prostate tissue while minimizing collateral damage.
- LIFE Method: Focused on selective tissue vaporization or enucleation, ensuring clean resection planes and predictable tissue removal.
Outpatient Feasibility
- Local Anesthesia: Allows many patients to undergo the procedure without the risks or recovery times associated with general anesthesia.
- Rapid Recovery: Less invasive than conventional transurethral resections, potentially reducing hospital stays and improving patient throughput.
Real-Time Visualization
- Precise Tissue Identification: Endoscopic imaging guides the laser fiber to the obstructive tissue, ensuring thorough clearance of the prostatic urethra.
- Controlled Ablation: The surgeon can finely tune laser energy to match the tissue’s vascularity and density, limiting the risk of deep thermal damage.
Efficient & Gentle Tissue Removal
- Targeted Laser Ablation: Precisely removes hyperplastic prostate segments that hinder urine flow, preserving healthy tissue zones.
- Hemostatic Effect: Laser energy also cauterizes small vessels during tissue vaporization, reducing intraoperative bleeding.
臨床上の利点と応用
Benign Prostatic Hyperplasia (BPH)
- Symptomatic Relief: Alleviates classic LUTS such as frequent urination, weak urine stream, and prolonged emptying times.
- Patient Selection: Suited for patients with moderate-to-severe BPH who seek a less invasive alternative to standard TURP or open prostatectomy.
Minimal Invasiveness
- Outpatient Possibility: Potentially performed under local anesthesia, minimizing hospitalization and facilitating early mobilization.
- Lower Bleeding Risk: Laser-based enucleation or vaporization significantly reduces hemorrhage compared to mechanical resection methods.
患者体験の向上
- Shorter Convalescence: Many patients resume daily activities sooner, with less postoperative discomfort or catheterization durations.
- Reduced Need for General Anesthesia: Local or spinal anesthesia lessens systemic risks, beneficial for older or comorbid patients.
Technical Specifications
仕様 | 詳細 / 価値 |
製品名 | CytroFIX® Superior Clavicula Plates |
素材 | High-Purity Titanium Alloy (e.g., Ti-6Al-4V ELI) |
Plate Profile | Low-profile, contoured for superior clavicle placement |
Locking Mechanism | Locking or non-locking titanium screws; optional variable-angle locking |
Screw Diameter | 2.7 mm or 3.5 mm (titanium cortical screws, depending on hole specification) |
Plate Thickness | ~2.0–2.5 mm (minimized profile) |
Hole Array | Multiple holes for bridging, compression, or combined fixation patterns |
ラジオパシティ | Titanium visible on fluoroscopy (optional etched markers) |
不妊症 | Provided non-sterile (autoclavable) or sterile, single use or reusable instrumentation (verify product line) |
賞味期限 | Indefinite if stored properly; reusable within recommended inspection cycles |
臨床適応症 | Midshaft/lateral clavicle fractures requiring superior plating, osteotomies, nonunion correction |
Regulatory Compliance | Conforms to ISO 13485, CE/FDA (region-specific), meets orthopedic implant standards |
Size & Ordering Matrix
Plate Length (mm) | Hole Count | Curvature | Compatible Screw | 商品コード | 備考 |
60 | 4 | Mild Superior Bend | 2.7 mm Locking/Non-Locking | CFX-SCL-60-4-27-Ti | Shorter plate for smaller fractures in lateral or mid-shaft |
70 | 5 | Mild Superior Bend | 2.7 mm Locking/Non-Locking | CFX-SCL-70-5-27-Ti | Extended coverage for mild to moderate fractures |
80 | 5 | Moderate Superior Bend | 2.7 or 3.5 mm Locking | CFX-SCL-80-5-MX-Ti | Bridges midshaft fractures with variable-angle options |
90 | 6 | Moderate Superior Bend | 3.5 mm Locking/Non-Locking | CFX-SCL-90-6-35-Ti | For larger or multi-fragment fractures requiring robust support |
100 | 7 | Enhanced Superior Contour | 3.5 mm Locking/Non-Locking | CFX-SCL-100-7-35-Ti | Accommodates more complex or extended fracture lines |
110 | 8 | Enhanced Superior Contour | 3.5 mm Locking/Non-Locking | CFX-SCL-110-8-35-Ti | Longest plate design for challenging multi-segment fractures |
関連商品
-
泌尿器科処置用ゼブラ・ガイドワイヤー
続きを読む泌尿器科インターベンションの精密ナビゲーションのために設計された柔軟で視認性の高いガイドワイヤーで、コントロールの向上、外傷の軽減、低侵襲手技の最適なサポートを保証する。
-
NeoAblate 腫瘍アブレーションプローブ(軟部組織・肝臓用
続きを読む低侵襲な腫瘍切除のために設計された精密工学機器であり、制御されたエネルギーを供給することで、周囲の健康な組織へのダメージを最小限に抑えながら、軟部組織や肝腫瘍を効果的に治療する。
-
StoneMaster: 石抽出バスケットのハイパフォーマー
続きを読む泌尿器科結石管理用に綿密に設計された器具で、優れたグリップ力、柔軟性、精度を備え、患者の不快感を最小限に抑えながら効率的に結石を捕捉・除去する。
-
Extender PTCAバルーンカテーテル
続きを読むA 標準 高圧 冠状動脈バルーン を想定している。 病変前置脱毛 またはスタンドアロン 血管形成術正確な膨張プロファイルと交差プロファイルの低減を提供する。